Related Experiment Videos
Molecular modelling studies on G protein-coupled receptors: from sequence to structure?
A S van Neuren1, G Müller, G Klebe
1Bayer AG, IM-FA, Computational Chemistry, Leverkusen, Germany.
Journal of Receptor and Signal Transduction Research
|March 11, 1999
Summary
Identifying transmembrane regions in G protein-coupled receptors (GPCRs) is crucial for drug design. Different sequence analysis tools yield conflicting results for these important membrane protein targets.
Area of Science:
- Pharmaceutical research
- Structural biology
- Computational chemistry
Background:
- G protein-coupled receptors (GPCRs) are key drug targets due to their prominent role in cellular signaling.
- GPCRs possess a characteristic seven-transmembrane helix bundle structure, crucial for ligand binding.
- Accurate structural models of GPCRs are vital for structure-based drug design and lead optimization.
Purpose of the Study:
- To comparatively evaluate various protein sequence analysis tools for identifying transmembrane segments in GPCRs.
- To highlight discrepancies in transmembrane region identification across different computational methods.
- To assess the reliability of these tools for modeling the 7TM domains of peptide-binding GPCRs.
Main Methods:
- Comparative analysis of protein sequence analysis tools (periodicity, multiple sequence alignment, directional helix descriptors).
- Application of these methods to prominent peptide-binding GPCRs (e.g., angiotensin II, CCK/gastrin, interleukin 8, endothelin).
- Evaluation of the accuracy and consistency of predicted transmembrane sequence stretches.
Main Results:
- Different sequence analysis tools produce contradictory results for identifying GPCR transmembrane domains.
- The accuracy of transmembrane segment prediction varies significantly among the evaluated methods.
- This inconsistency poses challenges for reliable GPCR structural modeling.
Conclusions:
- Careful selection and validation of sequence analysis tools are essential for accurate GPCR modeling.
- Further development of robust methods is needed for reliable prediction of transmembrane helices in GPCRs.
- Improved modeling of GPCR transmembrane domains will enhance structure-based drug discovery efforts.